Staging practices of primary non-small-cell lung cancer: A literature review

European Journal of Cancer Care

Volumn 15, Issue 4, 2006, Pages 348-354

  Alzahouri, K ^a,b   Martinet, Y ^c   Briancon S ^a,b   Guillemin, F ^a,b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c CHU NANCY BRABOIS   (France)

Author keywords

Clinical practice pattern; Imaging techniques; Invasive procedures; Non small cell lung cancer; Tumour staging

Indexed keywords

CANCER STAGING; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; PATHOLOGY; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING;

EID: 33748507610     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2006.00665.x     Document Type: Review

References (31)

1. BTS Guidelines (2001) Guidelines on the selection of patients with lung cancer for surgery. Thorax 56, 89-108.
2. Cabana M.D., Rand C.S., Powe N.R., Wu A.W., Wilson M.H., Abboud P.A. & Rubin H.R. (1999) Why don't physicians follow clinical practice guidelines? A framework for improvement. Journal of the American Medical Association 282, 1458-1465.
3. Cartman M.L., Hatfield A.C., Muers M.F., Peake M.D., Haward R.A. & Forman D. (2002) Lung cancer: district active treatment rates affect survival. Journal of Epidemiology and Community Health 56, 424-429.
4. Cerfolio R.J., Ojha B., Bryant A.S., Bass C.S., Bartalucci A.A. & Mountz J.M. (2003) The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Annals of Thoracic Surgery 76, 861-866.
5. Cetinkaya E., Turna A., Yildiz P., Dodurgali R., Bedirhan M.A., Gurses A. & Yilmaz V. (2002) Comparison of clinical and surgical-pathologic staging of the patients with non-small cell lung carcinoma. European Journal of Cardio-thoracic Surgery 22, 1000-1005.
6. De Leyn P., Vansteenkiste J., Cuypers P., Deneffe G., Van Raemdonck D., Coosemans W., Verschakelen J. & Lerut T. (1997) Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. European Journal of Cardio-thoracic Surgery 12, 706-712.
7. Depierre A., Lagrange J.L., Theobald S., Astoul P., Baldeyrou P., Bardet E., Bazelly B., Brechot J.M., Breton J.L., Douillard J.Y., Grivaux M., Jacoulet P., Khalil A., Lemarie E., Martinet Y., Massard G., Milleron B., Molina T., Moro-Sibilot D., Paesmans M., Pujol J.L., Quoix E., Ranfaing E., Riviere A., Sancho-Gamier H., Souquet J.P., Spaeth D., Stoebner-Delbarre A., Thiberville L., Touboul E., Vaylet F., Vergnon J.M. & Westeel V. (2003) [Standards, options and recommendations for the management of non-small cell lung carcinoma patients]. Bulletin du Cancer 90, 151-166.
8. Dujon A., Le Pimpec B.F., Saab M. & Riquet M. (2002) Routine mediastinoscopy and lymph node staging: 'much ado about nothing'? European Journal of Cardio-thoracic Surgery 22, 485.
9. ESMO (2001) Minimum clinical recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC). Annals of Oncology 12, 1049-1050.
10. Fergusson R.J., Gregor A., Dodds R. & Kerr G. (1996) Management of lung cancer in South East Scotland. Thorax 51, 569-574.
11. Gonzalez-Stawinski G.V., Lemaire A., Merchant F., O'Halloran E., Coleman R.E., Harpole D.H. & D'Amico T.A. (2003) A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery 126, 19001905.
12. Gregor A., Thomson C.S., Brewster D.H., Stroner P.L., Davidson J., Fergusson R.J. & Milroy R. (2001) Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 56, 212-217.
13. Grosclaude P., Galat J.P., Mace-Lesech J., Roumagnac-Machelard M., Mercier M. & Robillard J. (1995) Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France. British Journal of Cancer 72, 1278-1282.
14. Herder G.J., Verboom P., Smit E.F., van Velthoven P.C., van den Bergh J.H., van Colder C.D.M.I., van Mourik J.C., Postmus P.E., Teule G.J. & Hoekstra O.S. (2002) Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals. Thorax 57, 11-14.
15. Inoue K., Sato M., Fujimura S., Sakurada A., Takahashi S., Usuda K., Kondo T., Tanita T., Handa M., Saito Y. & Sagawa M. ( 1998) Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993. Journal of Thoracic and Cardiovascular Surgery 116, 407-411.
16. Janssen-Heijnen M.L., Gatta G., Forman D., Capocaccia R. & Coebergh J.W. (1998) Variation in survival of patients with lung cancer in Europe, 1985-1989. European Journal of Cancer 34, 2191-2196.
17. Kesson E., Bucknall C.E., McAlpine L.G., Milroy R., Hole D., Vernon D.R., Macbeth F. & Gillis C.R. (1998) Lung cancer - management and outcome in Glasgow, 1991-1992. British Journal of Cancer 78, 1391-1395.
18. Leonard C.T., Whyte R.I. & Lillington G.A. (2000) Primary non-small-cell lung cancer: determining the suitability of the patient and tumor for resection. Current Opinion in Pulmonary Medicine 6, 391-395.
19. Mackillop W.J., Dixon P., Zhou Y., Ago C.T., Ege G., Hodson D.I., Kotalik J.F., Lochrin C., Paszat L. & Harris D. ( 1994) Variations in the management and outcome of non-small cell lung cancer in Ontario. Radiotherapy and Oncology 32, 106-115.
20. McPherson K., Wemiberg J.E., Hovind O.B. & Clifford P. (1982) Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. New England foainal of Medicine 307, 1310-1314.
21. Margaritora S., Cesario A., Galetta D. & Granone P. (2001) Mediastinoscopy as a standardised procedure for mediastinal lymphnode staging in non-small cell carcinoma. Do we have to accept the compromise? European Journal of Cardio-thozacic Surgery 20, 652-654.
22. Melling P.P., Hatfield A.C., Muers M.F., Peake M.D., Storer C.J., Round C.E., Haward R.A. & Crawford S.M. (2002) Lung cancer referral patterns in the former Yorkshire region of the UK. British Journal of Cancer 86, 36-42.
23. Mountain C.F. (1997) Revisions in the international system for staging lung cancer. Chest 111, 1710-1717.
24. Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koeter G.H., Fidler V., Pruim J. & Groen H.J. (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. New England Journal of Medicine 343, 254-261.
25. Reed C.E., Harpole D.H., Posther K.E., Woolson S.L., Downey R.J., Meyers B.F., Heelan R.T., MacApinlac H.A., Jung S.H., Silvestri G.A., Siegel B.A. & Rusch V.W. (2003) Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery 126, 1943-1951.
26. Richardson G.E., Thursfield V.J. & Giles G.G. (2000) Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group. Medical Journal of Australia 172, 321-324.
27. Ringbaek T., Borgeskov S., Lange P. & Viskum K. (1999) Diagnostic and therapeutic process and prognosis in suspected lung cancer. Scandinavian Cardiovascular Journal 33, 337-343.
28. Smith T.J., Penberthy L., Desch C.E., Whittemore M., Newschaffer C., Hillner B.E., McClish D. & Retchin S.M. (1995) Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer 13, 235-252.
29. The National Comprehensive Cancer Network (2003) NCCN Non-Small-Cell Lung Cancer Practice Guidelines. Available at: http://www.nccn.org/physician_gls/ f_guidelines.html (accessed 6 May 2004).
30. van Tinteren H., Hoekstra O.S., Smit E.F., van den Bergh J.H., Schreurs A.J., Stallaert R.A., van Velthoven P.C., Comans E.F., Diepenhorst F.W., Verboom P., van Mourik J.C., Postmus P.E., Boers M. & Teule G.J. (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359, 1388-1393.
31. Walsh G.L. & Winn R.J. (1997) Baseline institutional compliance with NCCN guidelines: non-small-cell lung cancer. Oncology (Huntingt) 11, 161-170.